Technical brief: A novel strategy for enrichment of trabecular meshwork protease proteome

Molecular Vision

Volumn 14, Issue , 2008, Pages 871-877

  Picciani, Renata ^a   Junk, Anna K ^a   Bhattacharya, Sanjoy K ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; CYSTEINE PROTEINASE; PEPTIDE DERIVATIVE; PROTEINASE; PROTEINASE INHIBITOR; PROTEOME; PROTON; SERINE PROTEINASE; SODIUM CHLORIDE; TRYPSIN;

ADULT; AGED; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOSOL; FEMALE; HUMAN; HUMAN TISSUE; INCUBATION TIME; INTERMETHOD COMPARISON; INTRACELLULAR SPACE; MALE; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; TRABECULAR MESHWORK; ULTRAVIOLET RADIATION;

CHROMATOGRAPHY, AFFINITY; ELECTROLYTES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYMES, IMMOBILIZED; EYE PROTEINS; HUMANS; MASS SPECTROMETRY; PEPTIDE HYDROLASES; PEPTIDES; PROTEASE INHIBITORS; PROTEOME; PROTEOMICS; TIME FACTORS; TRABECULAR MESHWORK;

EID: 44149100285     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthahnol 1996; 80:389-93.
2. Morrison JC, Acott TS. Anatomy and physiology of aqueous humor outflow. In: Morrison JC, Pollack IP, editors. Glaucoma Science and Practice. New York: Thieme Medichl Publishers Inc.; 2003. p. 34-41.
3. Desmettre T, Rouland JF. Hypothesis on the role of nutritional factors in ocular hypertension and glaucoma. J Fr Ophtalmol 2005; 28:312-6.
4. Acott TS, Kelley MJ. Extracellular matrix in the trabecular meshwork. Exp Eye Res 2008; 86:543-61.
5. Buller C, Johnson D. Segmental variability of the trabecular meshwork in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 1994; 35:3841-51.
6. Govindarajan B, Laird J, Salomon RG, Bhattacharya SK. Isolevuglandin-modified proteins, including elevated levels of inactive calpain-1, accumulate in glaucomatous trabecular meshwork. Biochemistry 2008; 47:817-25.
7. Kaufman PL. Enhancing trabecular outflow by disrupting the actin cytoskeleton, inreasing uveoscleral outflow with prostaglandins, and understanding the pathophysiology of presbyopia interrogating Mother Nature: asking why, asking how, recognizing the signs, following the trail. Exp Eye Res 2008; 86:3-17.
8. Johnson DH. Histologic findings after argon laser trabeculoplasty in glaucomatous eyes. Exp Eye Res 2007; 85:557-62.
9. Friedl P, Brocker EB. The biology of cell locomotion within three-dimensional extracellular matrix. Cell Mol Life Sci 2000; 57:41-64.
10. Sanka K, Maddala R, Epstein DL, Rao PV. Influence of actin cytoskeletal integrity on matrix metalloproteinase-2 activation in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci 2007; 48:2105-14.
11. Alexander JP, Samples JR, Van Buskirk EM, Acott TS. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci 1991; 32:172-80.
12. Ronkko S, Rekonen P, Kaamiranta K, Puustjarvi T, Terasvirta M, Uusitalo H. Matrix metalloproteinases and their inhibitors in the chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol 2007; 245:697-704.
13. Keller KE, Kelley MJ, Acott TS. Extracellular matrix gene alternative splicing by trabecular meshwork cells in response to mechanical stretching. Invest Ophthalmol Vis Sci 2007; 48:1164-72.
14. Sanchez-Sanchez F, Martinez-Redondo F, Aroca-Aguilar JD, Coca-Prados M, Escribano J. Characterization of the intracellular proteolytic cleavage of myocilin and identificatiorrof calpain II as a myocilin-processing protease. J Biol Chem 2007;282:27810-24.
15. Rosenthal R, Choritz L, Zorn R, Munzer G, Fromm M, Pfeiffer N, Thieme H. Endothelin receptor B in trabecular meshwork. Exp Eye Res 2007; 85:482-91.
16. Righetti PG, Castagna A, Antonioli P, Boschetti E. Prefractionation techniques in proteome analysis: the mining tools of the third millennium. Electrophoresis 2005; 26:297-319.
17. Bhattacharya SK, Rockwood EJ, Smith SD, Bonilha VL, Crabb JS, Kuchtey RW, Robertson NG, Peachey NS, Morton CC, Crabb JW. Proteomics reveals cochlin deposits associated with glaucomatous trabecular meshwork. J Biol Chem 2005; 280:6080-4.
18. Gonzalez P, Epstein DL, Borras T. Genes upregulated in the human trabecular meshwork in response to elevated-intraocular pressure. Invest Ophthalmol Vis Sci 2000; 41:352-61.
19. Caballero M, Liton PB, Challa P, Epstein DL, Gonzalez P. Effects of donor age on proteasome activity and senescence in trabecular meshwork cells. Biochem Biophys Res Commun 2004; 323:1048-54.
20. Caballero M, Liton PB, Epstein DL, Gonzalez P. Proteasome inhibition by chronic oxidative stress in human trabecular meshwork cells. Biochem Biophys Res Commun 2003; 308:346-52.
21. Paik YK, Kim H, Lee EY, Kwon MS, Cho SY. Overview and introduction to clinical proteomics. Methods Mol Biol 2007; 428:1-32.
22. Kim H, Eliuk S, Deshane J, Meleth S, Sanderson T, Pinner A, Robinson G, Wilson L, Kirk M, Bames S. 2D gel proteomics: an approach to study age-related differences in protein abundance or isoform complexity in biological samples. Methods Mol Biol 2607; 371:349-91.
23. Reimer U, Reineke U, Schneider-Mergener J. Peptide arrays: from macro to micro. Curr Opin Biotechnol 2002; 13:315-20.
24. Tian R, Jiang X, Li X, Jiang X, Feng S, Xu S, Han G, Ye M, Zou H. Biological fingerprinting analysis of the interactome of a kinase inhibitor in human plasma by a chemiproteomic approach. J Chromatogr A 2006; 1134:134-42.
25. Daub H, Godl K, Brehmer D, Klebl B, Muller G. Evaluation of kinase inhibitor selectivity by chemical proteomics. Assay Drug Dev Technol 2004; 2:215-24.
26. Lolli G, Thaler F, Valsasina B, Roletto F, Knapp S, Uggeri M, Bachi A. Inhibitor affinity chromatography: profiling the specific reactivity of the proteome with immobilized molecules. Proteomics 2003; 3:1287-98.
27. Johnson S, Evans D, Laurenson S, Paul D, Davies AG, Ko Ferrigno P, Walti C. Surface-immobilized Peptide aptamers as probe molecules for protein detection. Anal Chem 2008; 80:978-83.
28. Freije R, Klein T, Ooms B, Kauffman HF, Bischbff R. An integrated high-performance liquid chromatography-mass spectrometry system fdr the activity-dependent analysis of matrix metalloproteases. J Chromatogr A 2008; 1189:417-25.
29. Freije JR, Klein T, Ooms JA, Franke JP, Bischoff R. Activity-based matrix metallo-protease enrichment using automated, inhibitor affinity extractions. J Proteome Res 2006; 5:1186-94.
30. O'Malley SM, Xie X, Frutos AG. Label-free high-throughput functional lytic assays. J Biomol Screen 2007; 12:117-25.
31. Monteiro RQ, Rezaie AR, Bae JS, Calvo E, Andersen JF, Francischetti IM. Ixolaris binding to factor X reveals a precursor state of factor Xa heparin-binding exosite. Protein Sci 2008; 17:146-53.
32. Smith JD, Chen A, Ernst LA, Waggoner AS, Campbell PG. Immobilization of aprotinin to fibrinogen as a novel method for controlling degradation of fibrin gels. Bioconjug Chem 2007; 18:695-701.
33. Ambudkar SV, Maloney PC. Bacterial anion exchange. Use of osmolytes during solubilization and reconstitution of phosphate-linked antiport from Streptococcus lactis. J Biol Chem 1986; 261:10079-86.
34. Kishore R, Reef Hardy W, Anderson VJ, Sanchez NA, Buoncristiani MR. Optimization of DNA extraction from low-yield and degraded samples using the BioRobot EZ1 and BioRobot M48. J Forensic Sci 2006; 51:1055-61.
35. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, Micheva KD, Mehalow AK, Huberman AD, Stafford B, Sher A, Litke AM, Lambris JD, Smith SJ, John SW, Barres BA. The classical complement cascade mediates CNS synapse elimination. Cell 2007; 131:1164-78.
36. Denis NJ, Vasilescu J, Lambert JP, Smith JC, Figeys D. Tryptic digestion of ubiquitin standards reveals an improved strategy for identifying ubiquitinated proteins by mass spectrometry. Proteomics 2007; 7:868-74.
37. Tomkinson B, Wernstedt C, Hellman U, Zetterqvist O. Active site of tripeptidyl peptidase II from human erythrocytes is of the subtilisin type. Proc Natl Acad Sci USA 1987; 84:7508-12.